The marketing department of a major drug company is refusing to do any work on the company's new cholesterol reducing drug.
Qi ffob, head of marketing, explained that their minimum standard for cholesterol drugs was cholesterol busting. “The public want and need cholesterol busting drugs. Anything less isn’t worth getting out of bed for. It may sound like marketing hype, but trust me, it is.” He went on to say that search engine users often typed in ‘cholesterol reducing’, sometimes typed ‘cholesterol obliterating’ and even ‘cholesterol annihilating’. ‘Busting’, therefore was the absolute minimum acceptable level of efficacy.
A dejected scientist said that although the new drug was effective at reducing cholesterol he understood that public expectations now demanded more than this. He summarised the situation as “Science 0, Idiots 1, again”.